Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Stoke Therapeutics Inc buy BTIG Research

Start price
€15.60
18.08.25 / 50%
Target price
€23.93
18.08.26
Performance (%)
7.05%
Price
€16.70
22.08.25
Summary
This prediction is currently active. The BUY prediction by BTIG_Research shows slight gains of 7.05%. This prediction currently runs until 18.08.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w
Stoke Therapeutics Inc 7.05%
iShares Core DAX® -0.099%
iShares Nasdaq 100 -1.085%
iShares Nikkei 225® -0.835%
iShares S&P 500 0.099%

Comments by BTIG_Research for this prediction

In the thread Stoke Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 7.05%
Target price 23.926
Change
Ends at 18.08.26

Stoke Therapeutics, Inc. (NASDAQ: STOK) was given a new $28.00 price target on by analysts at BTIG Research. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat